In vivo vulnerability to competition by endogenous dopamine: Comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride-Reference-Cited by-同舟云学术

In vivo vulnerability to competition by endogenous dopamine: Comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride

Published:2004 Issue:3 Volume:52 Page:188-208
ISSN:0887-4476
Container-title:Synapse
language:en
Short-container-title:Synapse

Author:

Narendran Rajesh,Hwang Dah-Ren,Slifstein Mark,Talbot Peter S.,Erritzoe David,Huang Yiyun,Cooper Thomas B.,Martinez Diana,Kegeles Lawrence S.,Abi-Dargham Anissa,Laruelle Marc

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience

Reference85 articles.

1. Alterations of Benzodiazepine Receptors in Type II Alcoholic Subjects Measured With SPECT and [123I]Iomazenil

2. PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756

3. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

4. Brain SPECT Imaging of Amphetamine-Induced Dopamine Release in Euthymic Bipolar Disorder Patients

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantification of [¹¹C]ABP688 binding in human brain using cerebellum as reference region: biological interpretation and limitations;2024-02-13

2. Advances in positron emission tomography imaging tracers for the central dopamine system;CHINESE J INORG CHEM;2024

3. Brain-iron deficiency models of restless legs syndrome;Experimental Neurology;2022-10

4. PET as a Translational Tool in Drug Development for Neuroscience Compounds;Clinical Pharmacology & Therapeutics;2022-02-24

5. Endogenous dopamine release in the human brain as a pharmacodynamic biomarker: evaluation of the new GPR139 agonist TAK-041 with [11C]PHNO PET;Neuropsychopharmacology;2021-10-21